Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016:2016:7297920.
doi: 10.1155/2016/7297920. Epub 2016 Oct 11.

Uveitis and Myositis as Immune Complications in Chemorefractory NK/T-Cell Nasal-Type Lymphoma Successfully Treated with Allogeneic Stem-Cell Transplant

Affiliations

Uveitis and Myositis as Immune Complications in Chemorefractory NK/T-Cell Nasal-Type Lymphoma Successfully Treated with Allogeneic Stem-Cell Transplant

Maria José Gómez-Crespo et al. Case Rep Hematol. 2016.

Abstract

NK/T-cell lymphomas are a group of clonal proliferations of NK- or, rarely, T-cell types and have peculiar clinicopathologic features. Most common site of involvement is the upper aerodigestive tract (nasal cavity, nasopharynx, paranasal sinuses, and palate). Association of autoimmune paraneoplastic disorders with NK/T-cell lymphomas is not well studied. Our patient was diagnosed with NK/T-cell lymphoma stage IV with skin involvement and treated frontline with CHOEP regimen. While he was under treatment, two immune complications presented: anterior uveitis of autoimmune origin refractory to steroids and myositis in lower limbs muscles. Autologous transplantation was rejected due to confirmed early relapse after first-line treatment, and the patient received second-line treatment according to the SMILE scheme, reaching complete response after four cycles. The patient underwent allogeneic transplantation and at the time of manuscript preparation is alive despite multiple complications. The disease should be suspected in patients with rhinitis or recurrent sinusitis, and early biopsy is recommended for all patients to avoid a delay in diagnosis. Our patient also presented symptoms of disease progression after first-line treatment, representing a paraneoplastic process, a very rare phenomenon in T-type lymphomas. This case is novel for the appearance of an inflammatory myositis, a histologically verified paraneoplastic phenomenon that responded to treatment for lymphoma.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a-b) Nasal lymphoma showing an initial ulcer that perforated into the oral cavity, opening a passage between the oral cavity and the nasal cavity. (c) Cutaneous manifestation of nasal-type extranodal NK/T-cell lymphoma. (d) Skeletal muscle fascicles revealing markedly distorted overall architecture with inflammatory interstitial infiltrate and endo and perimysial expansion. Perivascular lymphocytic inflammatory cluster with no signs of vasculitis. Myopathic changes suggestive of inflammatory myopathy. EBER negative. (e) Flow cytometry analysis of vitreous humor specimen: analysis is performed on cells consistent with leukocytes by FSC versus SSC and CD45. Flow cytometry demonstrates an aberrant NK-cell population (highlighted in red) with the following immunophenotype: CD3s−, CD56 (bright), CD7−, CD45+, HLA-DR−, CD5−, CD8−, and CD4− (see complete immunophenotype in text). Cells highlighted in cyan show a minor population of not aberrant NK cells and cells in red show reactive T cells. (f) MRI of the lower limbs revealing myositis infectious between the extensor digitorum longus and peroneus longus.

Similar articles

Cited by

References

    1. Tomonaga M. Outline and direction of revised WHO classification of Tumors of Haematopoietic and Lymphoid Tissues. Rinshō Ketsueki. 2009;50(10):1401–1406. - PubMed
    1. Kim S. H., Seon H. J., Choi Y. D., Yun S. J. Clinico-radiologic findings in primary cutaneous extranodal natural killer/T-cell lymphoma, nasal type mimicking cellulitis of the left arm. Iranian Journal of Radiology. 2015;12(1) doi: 10.5812/iranjradiol.12597.e12597 - DOI - PMC - PubMed
    1. Willemze R., Jaffe E. S., Burg G., et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768–3785. doi: 10.1182/blood-2004-09-3502. - DOI - PubMed
    1. Tse E., Kwong Y.-L. How I treat NK/T-cell lymphomas. Blood. 2013;121(25):4997–5005. doi: 10.1182/blood-2013-01-453233. - DOI - PubMed
    1. Lee J., Park Y. H., Kim W. S., et al. Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy. European Journal of Cancer. 2005;41(10):1402–1408. doi: 10.1016/j.ejca.2005.03.010. - DOI - PubMed

LinkOut - more resources